Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05870878Not ApplicableRecruiting

Generation R Next - Optimaal Opgroeien

Role: collaborator

NCT03924791Not ApplicableRecruiting

Transforaminal Epidural Injection in Acute Sciatica

Role: collaborator

NCT05606497Unknown

OPtimal TIming of COrticosteroids in Early-onset Fetal Growth REstriction: the OPTICORE Study

Role: collaborator

NCT01850719Not ApplicableCompleted

Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients

Role: collaborator

NCT01740037Not ApplicableCompleted

IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4

Role: collaborator

All 5 trials loaded